Refludan : étude de pharmacosurveillance = Refludan: pharmacosurveillance studyWINICKI, J.La Presse médicale (1983). 1998, Vol 27, pp 31-32, issn 0755-4982, SUP2Conference Paper

Antibodies against lepirudin are polyspecific and recognize epitopes on bivalirudinEICHLER, Petra; LUBENOW, Norbert; STROBEL, Ulrike et al.Blood. 2004, Vol 103, Num 2, pp 613-616, issn 0006-4971, 4 p.Article

Impact of smart infusion technology on administration of anticoagulants (Unfractionated heparin, Argatroban, Lepirudin, and Bivalirudin)FANIKOS, John; FIUMARA, Karen; BAROLETTI, Steve et al.The American journal of cardiology. 2007, Vol 99, Num 7, pp 1002-1005, issn 0002-9149, 4 p.Article

Refludan: Le premier traitement de la thrombopénie induite par l'héparine (TIH) de type II = Treatment of heparin-induced thrombocytopenia type IICAMEZ, A.La Presse médicale (1983). 1998, Vol 27, pp 28-30, issn 0755-4982, SUP2Conference Paper

Antithrombin activity of lepirudin adsorbed to silicone (polydimethylsiloxane) tubingHORNE, Mcdonald K; BROKAW, Kimberly J.Thrombosis research. 2003, Vol 112, Num 1-2, pp 111-115, issn 0049-3848, 5 p.Article

Comparison of monitoring methods for lepirudin: Impact of warfarin and lupus anticoagulantSALMELA, Birgitta; JOUTSI-KORHONEN, Lotta; SAARELA, Ellen et al.Thrombosis research. 2010, Vol 125, Num 6, pp 538-544, issn 0049-3848, 7 p.Article

Deep vein and intracardiac thrombosis during the post-partum period in Behçet's diseaseHIWARKAR, Prashant; STASI, Roberto; SUTHERLAND, George et al.International journal of hematology. 2010, Vol 91, Num 4, pp 679-686, issn 0925-5710, 8 p.Article

A direct thrombin inhibitor, lepirudin, for thrombophilic patients with inoperable critical limb ischemiaSALMELA, Birgitta; ALBÄCK, Anders; RÄIKE, Petri et al.Thrombosis research. 2009, Vol 123, Num 5, pp 719-723, issn 0049-3848, 5 p.Article

The Anti-Inflammatory Effects of Argatroban Can Be Differentiated from Other Direct Thrombin Inhibitors : Experimental and Clinical ObservationsHOPPENSTEADT, Debra A; JESKE, Walter; WALENGA, Jeanine M et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 97-102, issn 0094-6176, 6 p., SUP1Article

Lepirudin anticoagulation for heparin-induced thrombocytopenia after cardiac surgery in a pediatric patientKNODERER, Chad A; KNODERER, Holly M; TURRENTINE, Mark W et al.Pharmacotherapy. 2006, Vol 26, Num 5, pp 709-712, issn 0277-0008, 4 p.Article

Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin. CommentaryAREPALLY, Gowthami M; WARKENTIN, Theodore E; FRANCOIS, Dominique et al.Blood. 2006, Vol 108, Num 5, issn 0006-4971, 1428-1429,1492-1496 [7 p.]Article

Salvage late plasmapheresis in a patient with pulmonary embolism caused by heparin-lnduced thrombocytopenia primarily resistant to danaparoid sodium and lepirudinANTONIJEVIC, Nebojsa M; SAVIC, Nebojsa B; PERUNICIC, Jovan et al.Journal of clinical apheresis (Print). 2006, Vol 21, Num 4, pp 252-255, issn 0733-2459, 4 p.Article

Bidirectional glenn shunt surgery using lepirudin anticoagulation in an infant with heparin-lnduced thrombocytopenia with thrombosisIANNOLI, Ellen D; EATON, Michael P; SHAPIRO, Janine R et al.Anesthesia and analgesia. 2005, Vol 101, Num 1, pp 74-76, issn 0003-2999, 3 p.Article

Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studiesLUBENOW, Norbert; EICHLER, Petra; LIETZ, Theresia et al.Blood. 2004, Vol 104, Num 10, pp 3072-3077, issn 0006-4971, 6 p.Article

Treatment options for heparin-induced thrombocytopeniaGREINACHER, Andreas.American journal of health-system pharmacy. 2003, Vol 60, pp S12-S18, issn 1079-2082, SUP5Article

Effect of phenprocoumon on monitoring of lepirudin, argatroban, melagatran and unfractionated heparin with the PICT methodFENYVESI, T; JÖRG, I; HARENBERG, J et al.Pathophysiology of haemostasis and thrombosis (Print). 2002, Vol 32, Num 4, pp 174-179, issn 1424-8832, 6 p.Article

Point of care measurement of lepirudin and heparin anticoagulation during systemic inflammationHOMONCIK, Monika; PERNERSTORFER, Thomas; REITER, Rosemarie et al.Thrombosis research. 2002, Vol 108, Num 1, pp 91-95, issn 0049-3848, 5 p.Article

Antikoagulation bei HIT II: Wann therapeutisch-wann prophylaktisch? = Anticoagulation for HIT II: When should it be used Therapeutically and when as Prophylaxis?GREINACHER, A.AINS. Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. Sonderheft. 2002, Vol 37, Num 1, pp S3-S7, issn 1430-7790Article

Sites of elimination and pharmacokinetics of recombinant [¹³¹I]lepirudin in BaboonsMEIRING, S. M; LÖTTER, M. G; BADENHORST, P. N et al.Journal of pharmaceutical sciences. 1999, Vol 88, Num 5, pp 523-529, issn 0022-3549Article

Choix des médicaments pour traiter la thrombocytopénie induite par l'héparine = Choice of Drugs for Heparin-Induced ThrombocytopeniaThe Medical letter on drugs and therapeutics (Edition française). 2012, Vol 34, Num 13, pp 51-52, issn 0253-8512, 2 p.Article

Heparin-induced thrombocytopenia: Successful biological and clinical management with lepirudin despite severe renal impairmentDESCONCLOIS, Céline; RACT, Catherine; BOUTEKEDJIRET, Tewfik et al.Thrombosis and haemostasis. 2011, Vol 105, Num 3, pp 568-569, issn 0340-6245, 2 p.Article

Fondaparinux y lepirudina como alternativas terapéuticas ante una reacción cutánea eccematosa diseminada a heparina de bajo peso molecular = Fondaparinux and Lepirudin as Therapeutic Alternatives in a Disseminated Eczematous Skin Reaction to Low-Molecular-Weight HeparinSANTIAGO SANCHEZ-MATEOS, D. I; EGUREN, C; DE ARGILA, D et al.Actas dermo-sifiliográficas (Ed. impresa). 2010, Vol 101, Num 6, pp 556-558, issn 0001-7310, 3 p.Article

Anticoagulation in Patients with Heparin-Induced Thrombocytopenia undergoing Percutaneous Coronary Angiography and Interventions : Drugs in interventional cardiologyJOOST, Alexander; KUROWSKI, Volkhard; RADKE, Peter W et al.Current pharmaceutical design. 2008, Vol 14, Num 12, pp 1176-1185, issn 1381-6128, 10 p.Article

In Vitro Effects of Argatroban, Lepirudin, Bivalirudin, and Danaparoid on Fibrin Gel PermeabilitySHU HE; WALLEN, Hakan; JOHNSSON, Hans et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 91-96, issn 0094-6176, 6 p., SUP1Article

Risk of anaphylaxis after reexposure to intravenous lepirudin in patients with current or past heparin-induced thrombocytopeniaCARDENAS, Gustavo A; DEITCHER, Steven R.Mayo Clinic proceedings. 2005, Vol 80, Num 4, pp 491-493, issn 0025-6196, 3 p.Article